BusinessEsperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial ResultsBy Nasdaq OMXNov 3, 2016, 8:06 PM UTC
BusinessEsperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial ResultsBy Nasdaq OMXNov 3, 2016, 8:06 PM UTC
BusinessVocera Announces Third Quarter Revenue of $33.8 million and Raises FY’16 Revenue GuidanceBy Nasdaq OMXOct 27, 2016, 8:13 PM UTC
BusinessVocera Q3 2016 Results to be Released October 27, 2016By Nasdaq OMXOct 13, 2016, 12:02 PM UTC
BusinessLexington Realty Trust to Report Third Quarter 2016 Financial Results on November 3, 2016By Nasdaq OMXOct 11, 2016, 8:20 PM UTC
